DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: real-world experience from HCV-TARGET cohort | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: real-world experience from HCV-TARGET cohort

Verna EC, Morelli G, Terrault NA, et al. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: real-world experience from HCV-TARGET cohort. J Hepatol. 2020;S0168-8278(20):30193-30198.

Publication Type:

Journal Article

Authors:

Verna, EC; Morelli, G; Terrault, NA; et, al

Source:

J Hepatol, Volume S0168-8278, Issue 20, p.30193-30198 (2020)

Cited On:

Patients With Decompensated Cirrhosis

Export Citation:

RIS Format

Top